News

Telehealth company Hims & Hers Health (NYSE:HIMS) fell short of the market’s revenue expectations in Q2 CY2025, but sales ...
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) reported Q2 CY2025 results exceeding the market’s revenue expectations, ...